Moderna因美国官员反对疫苗接种而削减疫苗试验投资

美股速递
Jan 22

鉴于美国官员对疫苗接种的反对态度,Moderna, Inc. (MRNA) 正逐步缩减其在疫苗试验领域的资金投入。这一决策反映出公共卫生政策分歧对企业战略产生的直接影响。公司或将重新评估研发重点,以应对当前多变的市场环境。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10